Influenza A virus infection induces viral and cellular defective ribosomal products encoded by alternative reading frames

Journal of Immunology

Volumn 202, Issue 12, 2019, Pages 3370-3380

  Zanker, Damien J ^a   Oveissi, Sara ^a   Tscharke, David C ^b   Duan, Mubing ^a   Wan, Siyuan ^a   Zhang, Xiaomu ^a   Xiao, Kun ^a   Mifsud, Nicole A ^a,c   Gibbs, James ^d   Izzard, Lenny ^e   Dlugolenski, Daniel ^e   Faou, Pierre ^a   Laurie, Karen L ^f   Vigneron, Nathalie ^g   Barr, Ian G ^f   Stambas, John ^e   Van Den Eynde, Benoît J ^g   Bennink, Jack R ^d   Yewdell, Jonathan W ^d   Chen, Weisan ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e DEAKIN UNIVERSITY   (Australia)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; TUMOR NECROSIS FACTOR; INS1 PROTEIN, INFLUENZA VIRUS; VIRAL PROTEIN;

ALTERNATIVE READING FRAME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNOSURVEILLANCE; INFLUENZA A; INFLUENZA A VIRUS; INTERFERON PRODUCTION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; READING FRAME; RIBOSOME; RNA SPLICING; T LYMPHOCYTE ACTIVATION; VIRUS INFECTIVITY; VIRUS VIRULENCE; ALTERNATIVE RNA SPLICING; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFLUENZA; METABOLISM; OPEN READING FRAME; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY;

ALTERNATIVE SPLICING; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOLOGIC SURVEILLANCE; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; OPEN READING FRAMES; ORTHOMYXOVIRIDAE INFECTIONS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85067219326     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1900070     Document Type: Article

References (58)

1. Esquivel, F., J. Yewdell, and J. Bennink. 1992. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175: 163-168.
2. Croft, N. P., A. W. Purcell, and D. C. Tscharke. 2015. Quantifying epitope presentation using mass spectrometry. Mol. Immunol. 68(2, Pt A): 77-80.
3. Antón, L. C., and J. W. Yewdell. 2014. Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J. Leukoc. Biol. 95: 551-562.
4. Zook, M. B., M. T. Howard, G. Sinnathamby, J. F. Atkins, and L. C. Eisenlohr. 2006. Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. J. Immunol. 176: 6928-6934.
5. Berglund, P., D. Finzi, J. R. Bennink, and J. W. Yewdell. 2007. Viral alteration of cellular translational machinery increases defective ribosomal products. J. Virol. 81: 7220-7229.
6. Bullock, T. N., A. E. Patterson, L. L. Franlin, E. Notidis, and L. C. Eisenlohr. 1997. Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. J. Exp. Med. 186: 1051-1058.
7. Bullock, T. N. J., and L. C. Eisenlohr. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184: 1319-1329.
8. Chen, W., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, et al. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7: 1306-1312.
9. Cardinaud, S., A. Moris, M. Février, P. S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel. 2004. Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J. Exp. Med. 199: 1053-1063.
10. Maness, N. J., A. D. Walsh, S. M. Piaskowski, J. Furlott, H. L. Kolar, A. T. Bean, N. A. Wilson, and D. I. Watkins. 2010. CD8+ T cell recognition of cryptic epitopes is a ubiquitous feature of AIDS virus infection. J. Virol. 84: 11569-11574.
11. Maness, N. J., L. E. Valentine, G. E. May, J. Reed, S. M. Piaskowski, T. Soma, J. Furlott, E. G. Rakasz, T. C. Friedrich, D. A. Price, et al. 2007. AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape. J. Exp. Med. 204: 2505-2512.
12. Smirnova, E., A. E. Firth, W. A. Miller, D. Scheidecker, V. Brault, C. Reinbold, A. M. Rakotondrafara, B. Y. Chung, and V. Ziegler-Graff. 2015. Discovery of a small non-AUG-initiated ORF in poleroviruses and luteoviruses that is required for long-distance movement. PLoS Pathog. 11: e1004868.
13. Galindo, M. I., J. I. Pueyo, S. Fouix, S. A. Bishop, and J. P. Couso. 2007. Peptides encoded by short ORFs control development and define a new eukaryotic gene family. PLoS Biol. 5: e106.
14. Wise, H. M., A. Foeglein, J. Sun, R. M. Dalton, S. Patel, W. Howard, E. C. Anderson, W. S. Barclay, and P. Digard. 2009. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83: 8021-8031.
15. Jagger, B. W., H. M. Wise, J. C. Kash, K. A. Walters, N. M. Wills, Y. L. Xiao, R. L. Dunfee, L. M. Schwartzman, A. Ozinsky, G. L. Bell, et al. 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337: 199-204.
16. Muramoto, Y., T. Noda, E. Kawakami, R. Akkina, and Y. Kawaoka. 2013. Identification of novel influenza A virus proteins translated from PA mRNA. J. Virol. 87: 2455-2462.
17. Pala, P., H. C. Bodmer, R. M. Pemberton, J. C. Cerottini, J. L. Maryanski, and B. A. Askonas. 1988. Competition between unrelated peptides recognized by H-2-Kd restricted T cells. J. Immunol. 141: 2289-2294.
18. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158: 1507-1515.
19. Zanker, D., J. Waithman, J. W. Yewdell, and W. Chen. 2013. Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses. J. Immunol. 191: 52-59.
20. Chen, W., K. Pang, K. A. Masterman, G. Kennedy, S. Basta, N. Dimopoulos, F. Hornung, M. Smyth, J. R. Bennink, and J. W. Yewdell. 2004. Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination. J. Immunol. 173: 5021-5027.
21. Chen, W., J. R. Bennink, P. A. Morton, and J. W. Yewdell. 2002. Mice deficient in perforin, CD4+ T cells, or CD28-mediated signaling maintain the typical immunodominance hierarchies of CD8+ T-cell responses to influenza virus. J. Virol. 76: 10332-10337.
22. Chen, W., L. C. Antón, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12: 83-93.
23. Manicassamy, B., S. Manicassamy, A. Belicha-Villanueva, G. Pisanelli, B. Pulendran, and A. García-Sastre. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 107: 11531-11536.
24. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97: 6108-6113.
25. Chen, W., J. W. Yewdell, R. L. Levine, and J. R. Bennink. 1999. Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants. J. Exp. Med. 189: 1757-1764.
26. Pang, K. C., M. T. Sanders, J. J. Monaco, P. C. Doherty, S. J. Turner, and W. Chen. 2006. Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses. J. Immunol. 177: 7680-7688.
27. Kim, D., B. Langmead, and S. L. Salzberg. 2015. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12: 357-360.
28. Love, M. I., W. Huber, and S. Anders. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15: 550.
29. Bennink, J. R., and J. W. Yewdell. 1988. Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles. J. Exp. Med. 168: 1935-1939.
30. Reay, P. A., I. M. Jones, and G. G. Brownlee. 1988. A region of the influenza A/NT/60/68 PB2 protein containing an antigenic determinant recognized by murine H-2Dd restricted cytotoxic T lymphocytes. Virology 167: 261-268.
31. Tscharke, D. C., W. P. Woo, I. G. Sakala, J. Sidney, A. Sette, D. J. Moss, J. R. Bennink, G. Karupiah, and J. W. Yewdell. 2006. Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice. J. Virol. 80: 6318-6323.
32. Kim, Y., J. Sidney, S. Buus, A. Sette, M. Nielsen, and B. Peters. 2014. Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions. BMC Bioinformatics 15: 241.
33. Green, K. J., J. J. Miles, J. Tellam, W. J. van Zuylen, G. Connolly, and S. R. Burrows. 2004. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length. Eur. J. Immunol. 34: 2510-2519.
34. Ebert, L. M., Y. C. Liu, C. S. Clements, N. C. Robson, H. M. Jackson, J. L. Markby, N. Dimopoulos, B. S. Tan, I. F. Luescher, I. D. Davis, et al. 2009. A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. Cancer Res. 69: 1046-1054.
35. Probst-Kepper, M., V. Stroobant, R. Kridel, B. Gaugler, C. Landry, F. Brasseur, J. P. Cosyns, B. Weynand, T. Boon, and B. J. Van Den Eynde. 2001. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J. Exp. Med. 193: 1189-1198.
36. Dolan, B. P., J. J. Knowlton, A. David, J. R. Bennink, and J. W. Yewdell. 2010. RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis? J. Immunol. 185: 6728-6733.
37. Apcher, S., G. Millot, C. Daskalogianni, A. Scherl, B. Manoury, and R. Fåhraeus. 2013. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc. Natl. Acad. Sci. USA 110: 17951-17956.
38. Doronina, V. A., C. Wu, P. de Felipe, M. S. Sachs, M. D. Ryan, and J. D. Brown. 2008. Site-specific release of nascent chains from ribosomes at a sense codon. Mol. Cell. Biol. 28: 4227-4239.
39. Storz, G., Y. I. Wolf, and K. S. Ramamurthi. 2014. Small proteins can no longer be ignored. Annu. Rev. Biochem. 83: 753-777.
40. Stoner, G. D., Y. Kikkawa, A. J. Kniazeff, K. Miyai, and R. M. Wagner. 1975. Clonal isolation of epithelial cells from mouse lung adenoma. Cancer Res. 35: 2177-2185.
41. Chen, W., J. R. Bennink, and J. W. Yewdell. 2003. Systematic search fails to detect immunogenic MHC class-I-restricted determinants encoded by influenza A virus noncoding sequences. Virology 305: 50-54.
42. Kosík, I., J. Hollý, and G. Russ. 2013. PB1-F2 expedition from the whole protein through the domain to aa residue function. Acta Virol. 57: 138-148.
43. Chakrabarti, A. K., and G. Pasricha. 2013. An insight into the PB1F2 protein and its multifunctional role in enhancing the pathogenicity of the influenza A viruses. Virology 440: 97-104.
44. Bain, C., P. Parroche, J. P. Lavergne, B. Duverger, C. Vieux, V. Dubois, F. Komurian-Pradel, C. Trépo, L. Gebuhrer, G. Paranhos-Baccala, et al. 2004. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J. Virol. 78: 10460-10469.
45. Cardinaud, S., G. Consiglieri, R. Bouziat, A. Urrutia, S. Graff-Dubois, S. Fourati, I. Malet, J. Guergnon, A. Guihot, C. Katlama, et al. 2011. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope. PLoS Pathog. 7: e1002049.
46. Ingolia, N. T., G. A. Brar, N. Stern-Ginossar, M. S. Harris, G. J. Talhouarne, S. E. Jackson, M. R. Wills, and J. S. Weissman. 2014. Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. Cell Rep. 8: 1365-1379.
47. Stern-Ginossar, N., B. Weisburd, A. Michalski, V. T. Le, M. Y. Hein, S. X. Huang, M. Ma, B. Shen, S. B. Qian, H. Hengel, et al. 2012. Decoding human cytomegalovirus. Science 338: 1088-1093.
48. McLean, D. T., M. T. McCrudden, G. J. Linden, C. R. Irwin, J. M. Conlon, and F. T. Lundy. 2014. Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens. Regul. Pept. 194-195: 63-68.
49. Lauressergues, D., J. M. Couzigou, H. S. Clemente, Y. Martinez, C. Dunand, G. Bécard, and J. P. Combier. 2015. Primary transcripts of microRNAs encode regulatory peptides. Nature 520: 90-93.
50. Qian, X. Y., F. Alonso-Caplen, and R. M. Krug. 1994. Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J. Virol. 68: 2433-2441.
51. Dauber, B., J. Schneider, and T. Wolff. 2006. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J. Virol. 80: 11667-11677.
52. David, A., B. P. Dolan, H. D. Hickman, J. J. Knowlton, G. Clavarino, P. Pierre, J. R. Bennink, and J. W. Yewdell. 2012. Nuclear translation visualized by ribosome-bound nascent chain puromycylation. J. Cell Biol. 197: 45-57.
53. Prasad, S., S. R. Starck, and N. Shastri. 2016. Presentation of cryptic peptides by MHC class I is enhanced by inflammatory stimuli. J. Immunol. 197: 2981-2991.
54. Norbury, C. C., S. Basta, K. B. Donohue, D. C. Tscharke, M. F. Princiotta, P. Berglund, J. Gibbs, J. R. Bennink, and J. W. Yewdell. 2004. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
55. Tscharke, D. C., G. Karupiah, J. Zhou, T. Palmore, K. R. Irvine, S. M. Haeryfar, S. Williams, J. Sidney, A. Sette, J. R. Bennink, and J. W. Yewdell. 2005. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201: 95-104.
56. Yewdell, J. W. 2006. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25: 533-543.
57. Lin, L. C., I. E. Flesch, and D. C. Tscharke. 2013. Immunodomination during peripheral vaccinia virus infection. PLoS Pathog. 9: e1003329.
58. Yang, N., J. S. Gibbs, H. D. Hickman, G. V. Reynoso, A. K. Ghosh, J. R. Bennink, and J. W. Yewdell. 2016. Defining viral defective ribosomal products: standard and alternative translation initiation events generate a common peptide from influenza a virus M2 and M1 mRNAs. J. Immunol. 196: 3608-3617.